Oncogene - Table of Contents alert Volume 34 Issue 17

If you are unable to see the message below, click here to view.

Advertisement Four million CpGs - we've got you covered. Diagenod's Premium RRBS kit uses a proprietary protocol for highest efficiency of bisulfite conversion and minimal bias with reduced amplification requirements. High resolution DNA methylation profiling at the single nucleotide level Superior coverage - 4 million CpGs Cost-efficient - Optimized for multiplexing up 6 samples/lane  Learn more. TABLE OF CONTENTS Volume 34, Issue 17 (April 2015) In this issue Review Original Articles Short Communication Also new AOP Advertisement   Save up to 35% on your oligo costs. Introducing AUM's next generation oligo technology for efficient RNA silencing and regulation. Superior potency, delivery, stability & binding affinity. Reduced toxicity, immune stimulation & off target effects. Order oligos today for:  • Gene silencing • Exon skipping • Translation elongation inhibition (Steric blockers) • microRNA regulation (Antagomirs) • lncRNA and other non-coding RNA regulation • Decoys or Blockers. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Presented by Adaptive Biotechnologies, Nature Immunology, Nature Medicine, Nature Biotechnology, and Nature Genetics IMMUNE PROFILING IN HEALTH AND DISEASE September 9-11, 2015 | Seattle, WA, USA  REGISTER NOW!  Review Top Epigenetics in radiation-induced fibrosis C Weigel, P Schmezer, C Plass and O Popanda Oncogene 2015 34: 2145-2155; advance online publication, June 9, 2014; 10.1038/onc.2014.145 Abstract | Full Text Original Articles Top EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN L-M Cai, X-M Lyu, W-R Luo, X-F Cui, Y-F Ye, C-C Yuan, Q-X Peng, D-H Wu, T-F Liu, E Wang, F-M Marincola, K-T Yao, W-Y Fang, H-B Cai and X Li Oncogene 2015 34: 2156-2166; advance online publication, October 27, 2014; 10.1038/onc.2014.341 Abstract | Full Text Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells J Wang, O Mikse, R G Liao, Y Li, L Tan, P A Janne, N S Gray, K-k Wong and P S Hammerman Oncogene 2015 34: 2167-2177; advance online publication, June 9, 2014; 10.1038/onc.2014.161 Abstract | Full Text HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression S-D Chou, A Murshid, T Eguchi, J Gong and S K Calderwood Oncogene 2015 34: 2178-2188; advance online publication, June 23, 2014; 10.1038/onc.2014.177 Abstract | Full Text RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch L A Walsh, D M Roy, M Reyngold, D Giri, A Snyder, S Turcan, C R Badwe, J Lyman, J Bromberg, T A King and T A Chan Oncogene 2015 34: 2189-2203; advance online publication, June 16, 2014; 10.1038/onc.2014.175 Abstract | Full Text MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma V Mucaj, S S Lee, N Skuli, D N Giannoukos, B Qiu, T S K Eisinger-Mathason, M S Nakazawa, J E S Shay, P P Gopal, S Venneti, P Lal, A J Minn, M C Simon and L K Mathew Oncogene 2015 34: 2204-2214; advance online publication, June 23, 2014; 10.1038/onc.2014.168 Abstract | Full Text A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation Y Yan, A L Hein, P M Greer, Z Wang, R H Kolb, S K Batra and K H Cowan Oncogene 2015 34: 2215-2226; advance online publication, June 9, 2014; 10.1038/onc.2014.167 Abstract | Full Text Nuclear translocation of IGF-1R via p150Glued and an importin-β/RanBP2-dependent pathway in cancer cells S Packham, D Warsito, Y Lin, S Sadi, R Karlsson, B Sehat and O Larsson Oncogene 2015 34: 2227-2238; advance online publication, June 9, 2014; 10.1038/onc.2014.165 Abstract | Full Text mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3 K M Dodd, J Yang, M H Shen, J R Sampson and A R Tee Oncogene 2015 34: 2239-2250; advance online publication, June 16, 2014; 10.1038/onc.2014.164 Abstract | Full Text Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells T Kobayashi, K C Masoumi and R Massoumi Oncogene 2015 34: 2251-2260; advance online publication, June 9, 2014; 10.1038/onc.2014.159 Abstract | Full Text Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression I Akalay, T Z Tan, P Kumar, B Janji, F Mami-Chouaib, C Charpy, P Vielh, A K Larsen, J P Thiery, M Sabbah and S Chouaib Oncogene 2015 34: 2261-2271; advance online publication, June 16, 2014; 10.1038/onc.2014.151 Abstract | Full Text Short Communication Top Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases N Sausgruber, M-M Coissieux, A Britschgi, J Wyckoff, N Aceto, C Leroy, M B Stadler, H Voshol, D Bonenfant and M Bentires-Alj Oncogene 2015 34: 2272-2278; advance online publication, June 16, 2014; 10.1038/onc.2014.170 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.